Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

NCT04736173 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Nonsquamous Non Small Cell Lung Cancer
Squamous Non Small Cell Lung Cancer
Lung Cancer

Interventions

DRUG: Domvanalimab
DRUG: Zimberelimab
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Pemetrexed
DRUG: Pembrolizumab

Sponsor

Arcus Biosciences, Inc.

Collaborators

[object Object]